JPMorgan analyst Rachel Vatnsdal assumed coverage of Seer with a Neutral rating and $10 price target. The analyst maintained the firm’s current rating, price target, and estimates.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SEER:
- Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access Center
- Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their Studies
- Seer Reports First Quarter 2023 Financial Results
